Spinocerebellar Ataxia Type 7
Symptoms, Doctors, Treatments, Advances & More

Spinocerebellar Ataxia Type 7 Overview

Save information for later
Sign Up

Learn About Spinocerebellar Ataxia Type 7

View Main Condition: Movement Disorders

What is the definition of Spinocerebellar Ataxia Type 7?
Spinocerebellar ataxia 7 (SCA7) is an inherited disease of the central nervous system that leads to impairment of specific nerve fibers carrying messages to and from the brain, resulting in degeneration of the cerebellum (the coordination center of the brain). SCA7 differs from most other forms of SCA in that visual problems, rather than poor coordination, are generally the earliest signs of the disease. Affected individuals have progressive changes in vision (which can result in blindness); symptoms of ataxia; slow eye movements; and mild changes in sensation or reflexes. Later symptoms include loss of motor control, unclear speech (dysarthria), and difficulty swallowing (dysphagia). SCA7 is caused by genetic changes in the ATXN7 gene and is inherited in an autosomal dominant manner.
What are the alternative names for Spinocerebellar Ataxia Type 7?
  • Spinocerebellar ataxia 7
  • ADCA, TYPE II
  • Autosomal dominant cerebellar ataxia type 2
  • OPCA III
  • OPCA with macular degeneration and external ophthalmoplegia
  • OPCA with retinal degeneration
  • OPCA3
  • Olivopontocerebellar atrophy 3
  • SCA7
  • Spinocerebellar ataxia type 7
Who are the top Spinocerebellar Ataxia Type 7 Local Doctors?
Advanced in Spinocerebellar Ataxia Type 7
Advanced in Spinocerebellar Ataxia Type 7
Referral required

Swedish Neuroscience Specialists - Movement Disorders

550 17th Avenue, Suite 540, 
Seattle, WA 
206-320-5331
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Movement disorders are most effectively treated by adopting a multidisciplinary approach and closely collaborating with the patient, the family and other caregivers. Every member of the clinical team is invaluable in delivering high-quality, high-value care to patients and their families. Dr. Khemani is the Medical Director of the Movement Disorders Program within the Swedish Neuroscience Institute. Dr. Khemani is rated as an Advanced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 7. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Essential Tremor, Deep Brain Stimulation, and Orchiectomy. Dr. Khemani is board certified in American Board Of Psychiatry And Neurology. Dr. Khemani is currently accepting new patients.

Elite in Spinocerebellar Ataxia Type 7
Elite in Spinocerebellar Ataxia Type 7
Referral may be required
Xalapa De Enriquez, VER, MX 

Carlos Castillo-Hernandez practices practicing medicine in Xalapa De Enriquez, Mexico. Mr. Castillo-Hernandez is rated as an Elite expert by MediFind in the treatment of Spinocerebellar Ataxia Type 7. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 7, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Spinocerebellar Ataxia Type 4.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Spinocerebellar Ataxia Type 7
Elite in Spinocerebellar Ataxia Type 7
Referral may be required
Mexico, MEX, MX 

Victor Galvez practices practicing medicine in Mexico, Mexico. Mr. Galvez is rated as an Elite expert by MediFind in the treatment of Spinocerebellar Ataxia Type 7. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 7, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia.

View All Doctors
What are the latest Spinocerebellar Ataxia Type 7 Clinical Trials?
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)
Natural History of Spinocerebellar Ataxia Type 7 (SCA7)
Enrollment Status: Recruiting
Publish Date: June 05, 2026

Background: Spinocerebellar ataxia type 7 (SCA7) is a disease in which people have problems with coordination, balance, speech and vision. It is caused by a change in the ATXN7 gene. A mutation in this ATXN7 gene causes changes in eye cells, which can lead to vision loss. There is no cure for SCA7 but researchers are looking for possible treatments. Researchers need more information about SCA7. They want to c...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Riluzole in Patients With Spinocerebellar Ataxia Type 7: a Randomized , Double-blind, Placebo-controlled Pilot Trial With a Lead in Phase
Riluzole in Patients With Spinocerebellar Ataxia Type 7: a Randomized , Double-blind, Placebo-controlled Pilot Trial With a Lead in Phase
Who is this study for: Patients with spinocerebellar ataxia type 7
Enrollment Status: Recruiting
Publish Date: December 02, 2024
Intervention Type: Drug
Study Drug: Riluzole
Study Phase: Phase 2/Phase 3

Summary: Spinocerebellar ataxia type 7 (SCA7) belongs to the dominant forms of inherited cerebellar ataxias (CA), being one of the rarest form. SCA7 has no therapeutic options, so that the relentless course, the important visual deficit that accompanies CA, and the possibility of disease development in childhood are pressing unmet needs. The investigators published encouraging data on riluzole in inherited...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center